11 Most Profitable Stocks In Each Sector So Far in 2026
In a changing market landscape, investors are increasingly focused on profits and returns.
Erasca Inc. (ERAS)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 14,502,004 | $53,947,455 | 1.11% | |
| 2. | Paradigm Biocapital Advisors Senai Asefaw | 14,159,095 | $52,671,833 | +5% | 1.34% |
| 3. | Logos Capital Arsani William | 13,000,000 | $48,360,000 | -15% | 2.92% |
| 4. | Vivo Capital Albert Cha And Frank Kung | 9,273,428 | $34,497,152 | 2.23% | |
| 5. | Siren L.L.C. Raymond Debbane | 8,757,249 | $32,576,966 | 0.97% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.27 | 80,000 | $181,920.00 | 573,974 | 2024-05-21 | Filing | |
| $1.85 | 10,000 | $18,480.00 | 20,000 | 2023-12-06 | Filing | |
| $1.72 | 278,150 | $478,418.00 | 12,899,360 | 2023-12-06 | Filing | |
| $1.69 | 721,850 | $1,217,760.95 | 12,899,360 | 2023-12-05 | Filing | |
| $1.66 | 30,000 | $49,785.00 | 493,974 | 2023-12-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.40 | 80,000 | $1,312,000.00 | 25,076 | 2026-04-01 | Filing | |
| $15.04 | 20,000 | $300,760.00 | 0 | 2026-03-04 | Filing | |
| $5.59 | 120,000 | $670,812.00 | 25,076 | 2026-01-07 | Filing | |
| $18.77 | 200,000 | $3,753,000.00 | 10,305,553 | 2021-07-26 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,392 | $416,612 | 0% | |
| 2. | 7,397 | $119,683 | 0% | |
| 3. | 2,334 | $38,744 | 0% | |
| 4. | 2,004 | $32,425 | 0% | |
| 5. | 932 | $15,080 | 0.01% |
News See All
10 Best Performing Stocks of Q1 2026 to Watch for Q2
On April 3, Reuters reported that in the coming week, upcoming inflation data and initial company earnings could begin to show how the Middle East war is affecting the US economy and corporate America...
Erasca, Inc. (ERAS): A Bull Case Theory
We came across a bullish thesis on Erasca, Inc. on Danny’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on ERAS.
Mizuho Initiates Erasca (ERAS) With ‘Outperform’ Rating and $16 PT
On January 27, 2026, Mizuho initiated coverage of Erasca, Inc. (NASDAQ:ERAS) with an ‘Outperform’ rating and a $16 price target.
11 Best Performing Stocks in the Last 12 Months
The year 2025 was not just another year but a period marked by sharp shifts in technology, geopolitics, and trade policy, often driving markets in surprising ways, according to Reuters' year-end report...
Guggenheim More Than Doubles Erasca (ERAS) PT Following Clinical Progress and Updated Pipeline Models
Erasca Inc. (NASDAQ:ERAS) is one of the new stocks on the rise. On January 27, Guggenheim increased its price target for Erasca from $5 to $12 with a Buy rating.
10 New Stocks on the Rise
On January 21, Lynn Martin, NYSE president, joined CNBC's Sara Eisen to discuss the IPO landscape for 2026.
Erasca (ERAS) Soars 42% on Bullish Rating, PT Upgrade
Meanwhile, HC Wainwright also gave a price target of $11 versus $6 previously, with a “buy” recommendation, following Erasca Inc.’s (NASDAQ:ERAS) positive preliminary results from the clinical study...
Erasca (ERAS) Touches 3-Year High as 4 Analysts Go Bullish; Gets 267% PT Hike
Erasca notched another three-year high anew on Thursday, as investor sentiment continued to be fueled by four investment firms’ bullish outlooks for its stock, with the company earning a price target...
Erasca (ERAS) Hits Fresh High Anew as Firm Gets up to 267% PT Hike
Erasca extended gains to a second day on Wednesday to hit a new three-year high, as investors continued to load up on shares after earning 267 percent and 83 percent higher price targets from two investment...
Hedge Fund Resource Center